Atlas Trials

Nimotuzumab Combined With Radiotherapy in High-risk Patients With HNSCC Not Suitable for Cisplatin After Surgery

Clinical trial NCT05024019 · UNKNOWN

Trial details

NCT number
NCT05024019
Sponsor
Eye & ENT Hospital of Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Squamous Cell Carcinoma
Start date
2021-08-21
Primary completion
2025-08-21
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.